chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Raynaud's phenomenon in right hand with thumb going numb. This lasted about 30 minutes and was remedied by running hand under warm water, putting on warmer clothing and swinging arm like windmill to get blood flow back into hand.  I had experienced Raynaud's previously, but that was about 20 years ago and I lived in a colder climate back then when I would experience it during the winter months.  However, my fingers never went numb so the numb thumb was a new sensation.
Swelling redness pain at injection site x 4-5 days - better slowly over 3 wks but left with residual brachial neuritis.
SORE THROAT, HEADACHE, COUGH, FEVER, SINUS PAIN
received dose one of Shingrix in February of 2020 but has not yet received dose two.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 85-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received in February 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not received the 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter could not provide lot number and expiration date for dose one.  No exact date of administration of 1st dose was provided, only February of 2020. The reporter consented to follow up.
Right leg is swollen and hot. Patient has a rash around injection site. She was slightly feverish and was not feeling well.
It was reported that a 19 year old female pt received a Menomune A/C/Y/W-135 vaccination on 2/7/00 at 12:05. The pt did not eat since early in the morning. Approx. 12:20, the pt became pale, weak and nauseated, BP 60/42. The pt's feet were elevated and she was given juice and crackers. After a half an hour of rest, the pt's BP was 94/62. The pt reportedly, recovered from this experience. *F/UP report on 3/4/03: F/UP #1: During internal auditing of all files, it was necessary to amend the report by updating the adverse event coding (added pallor & hypotension).
patient inadvertently received an expired dose of Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 22-year-old female patient who received HAV (Havrix) (batch number H4H53, expiry date 31-JAN-2023) for prophylaxis.   On 01-AUG-2023, the patient received Havrix. On 01-AUG-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: patient inadvertently received an expired dose of Havrix). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 1-Aug-2023 The reporter consented to follow-up. The patient received an expired dose of Havirx, which led to expired vaccine used.
Janssen COVID-19 Vaccine EUA Dull headache increasing over time to a raging headache, Tylenol not helping much. 24 hours later, still have the raging headache. Body aches, intermittent soaking in hot bath tub to relieve pain.
red, swollen R arm 26 hours after vaccine - 10/27 7 pm warm to touch
A little bladder problems; urge to go to the bathroom/it's slowly goes out but I need to keep pushing and press to get the rest out mostly at night time; discomfort over the hair line; smell, face and blurry eye symptoms; smell, face and blurry eye symptoms/Blurry vision; taste foully taste, taste like chemical in something I eat; urge to go to the bathroom/it's slowly goes out but I need to keep pushing and press to get the rest out mostly at night time; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 60-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: Not reported), via an unspecified route of administration, administered in right arm on 07Apr2021 (at the age of 60-year-old) as DOSE 2, SINGLE for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number : Not reported), via an unspecified route of administration, administered in right arm on 16Mar2021 (at the age of 60-year-old) as DOSE 1, SINGLE for Covid-19 immunisation. She took the shot on last month on the 07Apr 2021, and at least a week after it got stronger. On 2021, the patient experienced a little bladder problems, urge to go to the bathroom/it's slowly goes out but she need to keep pushing and press to get the rest out, mostly at night time, discomfort over the hair line, smell, face and blurry eye symptoms and taste foully taste, taste like chemical in something she eat. Treatment not received for the adverse event. The patient underwent lab tests and procedures which included blood test: normal, everything look fine. They also took urine sample but not hear for the urine sample. (Further not clarified hence, not captured). Outcome of all the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Such bad side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Such bad side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Such bad side effects). At the time of the report, VACCINATION COMPLICATION (Such bad side effects) outcome was unknown.            No Concomitant product details were provided by the reporter. No Treatment information was provided.   Reporter did not allow further contact
Shingles; Information has been downloaded from Agency (US-BEH-2017077107).  This spontaneous report was received from a consumer referring to a 61-year-old male patient. The pertinent concurrent conditions, medical history and concomitant medications were not provided.  On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX), by subcutaneous route for unknown indication (concentration, number of dose administered, vaccination scheme, frequency, lot number and expiration date were not reported), and on 10-OCT-2016, the patient was vaccinated with influenza virus split virion 3v vaccine inactivated (AFLURIA) at a dose of 0.5 milliliter (ml), by intramuscular route, lot number WT57008 (strength, number of administered dose, vaccination scheme, frequency and expiration date were not reported) for unknown indication.     On 20-OCT-2016, the patient experienced shingles (herpes zoster). The outcome of herpes zoster was not reported.   The causality assessment between both vaccines and the aforementioned event was not reported.  The reporter considered the event was medically significant.
Patient started to get a runny nose around 2100 tonight. Denies any pain, no fever, nothing else, just  a running nose.
Pt woke up morning after flu vaccine with pain/swelling at injection site. Reports "both hands and feet very puffy/swollen. Unable to close hands." C/o some difficulty swallowing/some joint pain. No fever. Symptoms resolved over 25 hours with anti-histamine and pedi Advil.
Information has been received from a doctor of pathology concerning a female who was vaccinated with a first and second dose of varicella virus vaccine live. It was reported that the patient failed to seroconvert. The physician stated that the infectious control department would handle the reporting of vaccine failure. Unspecified medical attention was sought. No further information is available.
I contracted COVID 19 3/24/22 with symptoms of fatigue, scratchy throat, headache. I was ill for 5 to 7 days, but the fatigue lingered for 2 weeks.
Migraine; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included montelukast sodium (SINGULAIR), budesonide, formoterol fumarate (SYMBICORT), cetirizine hydrochloride (ZYRTEC), fexofenadine hydrochloride (ALLEGRA) and famotidine (MANUFACTURER UNKNOWN); all from an unknown date for unknown indications. The patient previously took pertussis vaccine (MANUFACTURER UNKNOWN) and eletriptan hydrobromide (REPLAX) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 15Apr2021 at 15:00, the patient experienced migraine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included treatment with acetaminophen (EXCEDRIN). The clinical outcome of the event migraine was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tachycardia; severe weakness; numbness; lightheadedness; sweaty; itchy around her neck; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (tachycardia), ASTHENIA (severe weakness), HYPOAESTHESIA (numbness), DIZZINESS (lightheadedness) and HYPERHIDROSIS (sweaty) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced TACHYCARDIA (tachycardia), ASTHENIA (severe weakness), HYPOAESTHESIA (numbness), DIZZINESS (lightheadedness), HYPERHIDROSIS (sweaty) and PRURITUS (itchy around her neck). On 14-Jan-2021, TACHYCARDIA (tachycardia), ASTHENIA (severe weakness) and DIZZINESS (lightheadedness) had resolved. At the time of the report, HYPOAESTHESIA (numbness), HYPERHIDROSIS (sweaty) and PRURITUS (itchy around her neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: tingling in the hand
An 8 year old female experienced fever on 1/12/01 after receiving RabAvert for post-exposure prophylaxis. The pt was bitten by a stray cat and the cat was not found. She received human rabies immune globulin and the 1st dose of RabAvert on day 0, 1/9/01, with no adverse events. By day 3, 1/12/01, the pt had a fever of 100F, probably from bronchitis. She was given her 2nd dose of RabAvert. That night, her fever rose to 106F and her mother gave her Advil and Tylenol. The fever subsided, and she recovered on 1/16/01. The pt then received RabAvert on 1/18/01, 1/22/01 and 2/5/01. She is currently taking Cefzil for bronchitis, Albuterol inhaler for chronic asthma and Delsym. No further problems were noted.
Fluarix exposed to below 0 C; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Flu Seasonal TIV Dresden (Fluarix) (batch number UT8040JA, expiry date 30-JUN-2024) for prophylaxis.   On an unknown date, the patient received Fluarix. On an unknown date, an unknown time after receiving Fluarix, the patient experienced incorrect storage of drug (Verbatim: Fluarix exposed to below 0 C). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 18-Oct-2023 The reporter mentioned that it might be a sanofi vaccine.  The reporter did not see in the batch.  Documenting just in case.  Consented to follow up via email. Fluarix exposed to below 0 C and was administered to over 86 people at a flu clinic, which led to incorrect storage of drug.
Currently pregnant at 27 weeks, 3 days - estimated due date October 31. Adverse event happened about 2 weeks after the first dose: Redness, slight swelling, tenderness and itching around and surrounding injection site. The patch is irregular in shape and relatively large (about 6 inches long, 3-4 inches wide). Looks like "Covid Arm". Started itching a couple days ago (thought it was a mosquito bite) and eventually spread over the next day. There were no other adverse effects aside from a sore arm immediately after the shot was given.
A report has been received from a Health Professional concerning an 18 year Female patient, who was prescribed Nasal FLUMIST QUADRIVALENT, 0.2 Millilitres, started on an unknown date. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced expired dose. The outcome of the event of expired dose was unknown. The reporter's description of the event was as follows: None reported. The report was considered to be non-serious.
This Non valid spontaneous report was received from a registered nurse and refers to an unspecified number of unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On dates on or after 21-SEP-2017, the patients were vaccinated with improperly stored dose of PEDVAXHIB for prophylaxis, lot# N000238 with expiration date of 25-OCT-2019, lot# N003701 with expiration date of 01-NOV-2019, lot# N008079 with expiration date of 02-DEC-2019, lot# N012920 with expiration date of 07-FEB-2020 (strength, dose, route and frequency were not reported); or with improperly stored dose of RECOMBIVAX HB for prophylaxis, lot# N020613 with expiration date of 05-MAY-2020, lot# N002202 with expiration date of 04-NOV-2019, lot# N011851 with expiration date of 19-DEC-2019; or with improperly stored dose of ROTATEQ orally, for prophylaxis, lot# N000175 with expiration date of 20-SEP-2018, lot# N005618 with expiration date of 04-OCT-2018, lot# N005078 with expiration date of 22-NOV-2018; or with improperly stored dose of VAQTA for prophylaxis, reported lot# M019924 with expiration date of 02-SEP-2018, lot# N008823 with expiration date of 26-MAY-2018. No adverse effects were reported. It was stated that the vaccines underwent a temperature excursion of 32°F (degrees Fahrenheit) to 35°F for 40 minutes; No previous temperature excursion was done. The call was because of a "data logger". This is a non-valid case due to lack of patient identifier. Follow up information was received from the registered nurse 30-APR-2018. The nurse stated the temperature excursion was stable and they had two refrigerators that held the related vaccines. The nurse was not able to provide patients' names or initials, or ages, but was able to provide number of patients, gender information, and vaccination dates. This report referred to a female patient vaccinated with improperly stored VAQTA (lot# N019924 with expiration date 02-SEP-2018) on 21-SEP-2017. Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received. This is one of several reports received form the same reporter (link reports: 1710USA004069, 1805USA001661, 1805USA004617, 1805USA004618, 1805USA004590, 1805USA004591, 1805USA004592, 1805USA004593, 1805USA004674, 1805USA004675, 1805USA004676, 1805USA004677, 1805USA004678, 1805USA004679, 1805USA004680, 1805USA004681, 1805USA004682, 1805USA004683, 1805USA004968, 1805USA004969, 1805USA004970, 1805USA004971, 1805USA004972, 1805USA004973, 1805USA004974, 1805USA004975, 1805USA004976, 1805USA004977, 1805USA004978, 1805USA004979, 1805USA004980, 1805USA004981, 1805USA004982).
Itchy rash started on arms and legs the evening after the vaccines were given and progressively got worse and spread.
Moderna COVID-19 Vaccine             Chills and shaking at 6 PM day of shot.  Then 36 hours later at 11PM next day (3-9-2021) had SEVERE Shaking and Chills. This lasted 45 minutes. I could hardly walk and was not able to take full breaths.  The next day felt awful but realized that I had had a deep muscle massage, the HARD Way.  I drank a lot of water, much more than usual to get rid of toxins. The following day I felt fine.
large wheal w/induration/whealing rt deltoid w/multiple papular type eruptions around site;warm to touch;
low-grade fever around 100; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low-grade fever around 100) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (low-grade fever around 100). At the time of the report, PYREXIA (low-grade fever around 100) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) low-grade fever around 100.         No concomitant medications were reported. Treatment medications were not provided by the reporter.  Patient had the booster shot on Thursday.
Shot was provided in back of left arm, after a few hours arm began to swell overnight a knot developed, received a COVID booster two days later (9 Nov 22), by this time the swelling/redness on the back of my arm was palm sized, technician said I needed to report.
Mania.  All antidepressants can induce mania, although fluoxetine Rx taken 10 years earlier without this adverse effect.
This spontaneous report as received from an medical assistant refers to a unspecified number of patients (age and gender unknown). On unknown dates the patients were vaccinated with improperly stored VAQTA dose, route of administration and lot# were not reported. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 15-Oct-2021, PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Concomitant information was not reported.Treatment information was not reported.Most recent FOLLOW-UP information incorporated above includes:On 22-Nov-2021: Follow-up received includes updated patient identifier.
pt recv vax 2JUN95 c/o swelling & pain rt arm 3JUN95; presented to ER 8JUN95 rt arm swollen hand & painful;
pruritic rash on upper chest & back w/itching; onset 22JUL95 w/progressive worsening to present;
Janssen COVID-19 Vaccine EUA Starting on 4/11/21 at around 12:00 pm I started to have a numbness on both sides of my face. It felt as though there were pins and needles throughout my face. I would say that it was a 4/10 in terms of intensity. At first I thought maybe it was due to drinking coffee without food or other water (I don't regularly drink coffee but I have never had these symptoms from coffee before). However, even after eating food and drinking a sugary drink around 4:00 pm, the pins and needles remained. The symptoms began to subside at 6 pm or 7 pm.  The only other normal symptoms that I had were feeling tired on 4/8/21 and 4/9/21. Also, on 4/9/21 I had very slight muscle soreness throughout my body. I have also had difficulty concentrating which may or may not be related.
tingling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (tingling at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PARAESTHESIA (tingling at injection site). At the time of the report, VACCINATION SITE PARAESTHESIA (tingling at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up received on 16-Apr-2021 included no new information.
First day of my last period was Feb 11, 2021. I was pregnant for 11 weeks, and had a miscarriage on April 29, 2021.
The patient was given the pfizer vaccine and then was standing watch her brother gets his. She all the sudden fainted and dropped to the floor. We rushed over and put her feet in the air on a chair and checked her BP and pulse ( 115/70,  71). She didn't look pale or sweaty or any other symptoms per patients response.  We gave her an ice pack for head and had her lay down for 15mins. I repeated the BP/pulse and still WNL.
Sinus Bradycardia, 40s, Four months after 2nd dose, repeating every month for a couple days.  Bradycardia continues till today with last two episodes one week apart.  Episodes last approx. 40 hours.  Resting HR in 60s - 70s instead of 70s - 80s.
Hives to torso, upper arms & groin area. Itching but no redness to lower extremities, occurring approx 5-6 hrs post/vax. Treated with Benadryl 25mg at home. Calamine lotion also applied topically after hives began to resolve.
Patient experienced shakes, was achy all over, and was freezing cold. The symptoms started about 6.5 hours after having the vaccine.